tarahcarvosso1/tarah1998
1
0
Code Issues Actions Packages Projects Wiki

Add An update on testosterone, HDL and cardiovascular risk in men

Tarah Carvosso 2026-04-03 01:34:45 +00:00
commit 006854f501
1 changed files with 7 additions and 0 deletions
Show Stats Download Patch File Download Diff File Expand all files Collapse all files

7
An-update-on-testosterone%2C-HDL-and-cardiovascular-risk-in-men.md Normal file

@ -0,0 +1,7 @@
<br>
<br>Crisostomo et al44 performed a study examining [testosterone store](http://175.178.252.59:18908/ednahynes34731) and death signaling in rats. Because estrogen deficiency is a principal cause of bone loss, Bellido et al50 examined the effects of [buy testosterone online](http://121.199.174.122:3000/jodyridenour81) on IL‐6 as it pertains to osteoblastic cell lines. The authors suggested that testosterone may act directly on CD4+ lymphocytes.48 This may lead to advancements in MI therapy, as inflammation is one of the factors of early remodeling, which causes the left ventricle to dilate and become less efficient.47 Attenuating myocardial remodeling may lead to improved ejection fraction and long‐term survival in patients with MI.47 As IL‐10 is a Th2 anti‐inflammatory cytokine, this study suggested that [buy testosterone cream](http://47.92.23.195:8418/myleskobayashi/myles2024/wiki/Risks-of-Illegal-Testosterone) triggered a reduction in inflammation. Testosterone‐treated splenic cells showed increased IL‐10 secretion compared with cells treated with placebo. Researchers in this study found that [buy testosterone booster](http://59.110.175.62:4322/juliussaiz1235) significantly decreased the interferon‐γ/interleukin‐10 (IFN‐γ/IL‐10) ratio by decreasing IFN‐γ and Th1 proimflammatory cytokines and increasing IL‐10 concentration.48 This suggests that testosterone attenuates the IFN‐γ inflammatory pathway and enhances the IL‐10 pathway. Not all studies involving inflammatory pathways are cardiovascular in nature, as seen in Table 3.
Second, the modulation of intracellular cAMP by Tes may occur via the sex hormone-binding globulin-Tes complex and may be biologically active via its binding to cell-surface sex hormone-binding globulin receptors that evoke an increase in intracellular cAMP. First, in VSM cells, Tes stimulates NO production (via neuronal NOS), which in turn evokes the formation of cGMP (via guanylyl cyclase) to induce vasorelaxation (8, 68). Moreover, Tes may also cause vasorelaxation by modulating intracellular signal transduction pathways such as increasing the levels of cGMP (8) and cAMP (41), which may indeed evoke vasorelaxation. In porcine coronary myocytes, 200 nM Tes very dramatically activated BKCa channels, increasing the open probability by more than 10-fold (8). Furthermore, the authors (41) presented data revealing that the vasodilatory action of the 5β-reduced metabolite of Tes, 5β-DHT, involves the inhibition of VOCCs from nanomolar to micromolar concentrations (100 nM–32 μM).
Because of this controversy, we sought to determine the current status of basic science studies that have examined the effects of testosterone on the cardiovascular system in experimental models. This randomized controlled trial of elderly, frail men was halted early by the data safety monitoring board due to an excess of cardiovascular events noted among older men randomized to testosterone as compared with placebo. Although cross-sectional studies have demonstrated higher prevalence of CVD among men with low endogenous androgens, limited clinical data have not shown that testosterone replacement therapy (TRT) reduces CVD risk. We also take a closer look at effects of [buy testosterone gel online](https://career.agricodeexpo.org/employer/110046/stress-cortisol-and-male-performance-the-connection-utzy-naturals) on lipids and HDL in particular, to see if this explains the cardiovascular effects seen in clinical studies. Since several recent studies have revealed that these nonaromatizable metabolites are fully capable of causing vascular relaxation (8, 10, 47, 48, 50, 73), the established concept that Tes is metabolized to inactive excretory metabolites must then be discarded when considering the effects of androgens on cardiovascular function. The well-established clinical observations that hypertension (HT) and coronary artery disease occur more frequently in men than in premenopausal women (26–28, 30, 31, 38, 69) have led to the dogmatic concept that [testosterone order](https://www.culpidon.fr/@deliafox879883) (Tes) has deleterious effects on the heart and vasculature and exacerbates the development of CVD in males (18, 37, 54).
When compared with the control (intact) males, both groups of treated males showed decreases in proapoptotic signaling, suggesting that [buy testosterone booster](https://videofrica.com/@1775143785361383) is proapoptotic and is harmful to cardiomyocytes during ischemia and reperfusion.56 Researchers found that after ischemia and reperfusion, castrated male and flutamide‐treated male hearts showed decreased caspase‐1, caspase‐3, caspase‐11, TNF‐α, IL‐1β, IL‐6, and activated p38 MAPK in conjunction with increased Bcl‐2 expression. Western blot analysis revealed upregulation of caspase‐3 (apoptotic) and downregulation of Bcl‐2 (antiapoptotic) in the [buy testosterone](http://35.207.205.18:3000/nellefortin98) group compared with the controls.44 Estrada et al and Jia et al found similar effects of testosterone in the caspase‐3 and Bcl‐2 pathways, respectively, further suggesting a proapoptotic function of [buy testosterone supplements](http://115.190.112.247:8418/thadtolbert544).54–55 Heart disease is the leading cause of death in both sexes.53 The concept of cardiomyocyte death signaling during ischemic heart disease and the role of [testosterone for sale](http://115.190.101.235:18080/rethadigiovann/5323972/wiki/Recognizing-the-True-Value-of-Testosterone-Therapy-in-Health-Care) merits investigation.
Since day-to-day variation of T concentrations in a given individual can be large , these single low measurements may not be as meaningful as multiple measurements over time. The inconsistency among the longitudinal data may in part be due to the design of such studies and the reliance on single, or even duplicate measures of serum T. Moreover, appropriately powered randomized controlled trials of TRT, the gold standard for determining the risks and benefits of a clinical intervention, have not been performed. Articles from American Journal of Physiology - Heart and Circulatory Physiology are provided here courtesy of American Physiological Society Therefore, it is reasonable to propose that 1) an insufficiency of androgens during pregnancy, particularly 5β-DHT, could contribute, at least in part, to the development of preeclampsia/eclampsia and [1.13.196.248](http://1.13.196.248:3000/hwoaleida91189/aleida1987/wiki/Primary-Testicular-Failure-Endotext-NCBI-Bookshelf) 2) exogenously administered 5β-DHT may be therapeutically relevant for the treatment of gestational HT.
<br>